US Map / Washington
State WA

Clinical Trials in Washington

Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.

Total Trials
246
Recruiting Now
246
← Back to US Map
Top Conditions in Washington
Breast Cancer (6)Chronic Lymphocytic Leukemia (4)Endometrial Cancer (4)Advanced Solid Tumor (4)Ovarian Cancer (4)Anatomic Stage II Breast Cancer AJCC v8 (3)Multiple Myeloma (3)Bipolar I Disorder (3)Obesity (3)Acute Myeloid Leukemia (3)Small Lymphocytic Lymphoma (3)Head and Neck Squamous Cell Carcinoma (3)

Frequently Asked Questions — Clinical Trials in Washington

How many clinical trials are currently recruiting in Washington?
ClinicalMetric currently tracks 246 actively recruiting clinical trials with at least one location in Washington. The total number of registered studies—including active but not currently enrolling trials—is 246. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington?
Washington hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Chronic Lymphocytic Leukemia, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington?
To join a clinical trial in Washington, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington

NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05410977 N/A
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neopl...
Condition
Colorectal Carcinoma
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
View Trial →
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
View Trial →
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
View Trial →
NCT06517875 Phase 2
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Trans...
Condition
Primary Myelofibrosis
Enrollment
68 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
View Trial →
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
View Trial →
NCT07199829 N/A
Recruiting
Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel
Condition
Hypovitaminosis D
Enrollment
96 pts
Location
United States
Sponsor
Madigan Army Medical Center
View Trial →
NCT05135403 N/A
Recruiting
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Condition
Sudden Cardiac Arrest
Enrollment
5,179 pts
Location
United States
Sponsor
Kestra Medical Technologies, I
View Trial →
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
View Trial →
NCT01703429 N/A
Recruiting
Complementary and Alternative Care in Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
1,000 pts
Location
United States
Sponsor
Bastyr University
View Trial →
NCT05930483 N/A
Recruiting
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Can...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
640 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
View Trial →
NCT07097792 N/A
Recruiting
Concussion Recovery and Support Program
Condition
Brain Concussion
Enrollment
40 pts
Location
United States
Sponsor
Seattle Children's Hospital
View Trial →
NCT06238492 N/A
Recruiting
A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI
Condition
Spinal Cord Injuries
Enrollment
24 pts
Location
United States
Sponsor
Kessler Foundation
View Trial →
NCT07228117 N/A
Recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adult...
Condition
Type 1 Diabetes Mellitus
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Medtronic MiniMed, Inc.
View Trial →
NCT06812832 Phase 4
Recruiting
Simethicone as Part of ERAS in Bariatric Surgery Patients
Condition
Simethicone
Enrollment
260 pts
Location
United States
Sponsor
Madigan Army Medical Center
View Trial →
NCT06516952 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant...
Condition
Prurigo Nodularis
Enrollment
330 pts
Location
United States, Argentina, Austria
Sponsor
Incyte Corporation
View Trial →
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
View Trial →
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
View Trial →
NCT04177914 Phase 3
Recruiting
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Condition
Hydrocephalus
Enrollment
176 pts
Location
United States, Canada
Sponsor
University of Utah
View Trial →
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cerebl...
Condition
Multiple Myeloma
Enrollment
135 pts
Location
United States, Australia, Canada
Sponsor
AbbVie
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 1 of 10 — 246 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology